Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 161

Sort by

Sort Order Select

Journal Articles

Leptin-Enhanced JAK-STAT Signaling in Acute Myeloid Leukemia-Derived Mesenchymal Stromal Cells and Its Implications for Disease Progression

Muzaffar Bhatti, Anthea Travas, Oyeronke Ayansola, Amirthagowri Ambalavanan, Jaeyoon John Kim, Danielle Pyne, Troy Ketela, Andrea Arruda, Mark D. Minden, Armand Keating, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 5664.

https://doi.org/10.1182/blood-2024-211349

Published: 2024

Journal Articles

The Use of Post-Transplant Cyclophosphamide Leads to Increased Cardiac Complications without Affecting Survival in Haploidentical Stem Cell Transplantation

Tommy Alfaro, Nihar Desai, Maria Queralt Salas, Carol Chen, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Wilson Lam, Arjun Law, Jeffrey H. Lipton, Fotios Michelis, Igor Novitzky-Basso, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 7289.

https://doi.org/10.1182/blood-2024-205817

Published: 2024

Journal Articles

Real-World Experience of Asciminib Treatment and Its Clinical Outcomes Including Cardiovascular (CV) Event-Free, Failure-Free Survival Associated with CV Comorbidity and Framingham CV Risk Score in Patients with Chronic Myeloid Leukemia

Mohammad Alwadi, May Chiu, Gopila Gupta, Maria Agustina Perusini, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 6618.

https://doi.org/10.1182/blood-2024-211439

Published: 2024

Journal Articles

The Effect of Smoking and Pre-Transplant Pulmonary Comorbidity on the Incidence of Lung Graft Versus Host Disease and Post Transplant Outcomes

Mohammed Kawari, Mariana Pinto Pereira, Mats Remberger, Ambrose Lau, Arjun Law, Rajat Kumar, Igor Novitzky-Basso, Wilson Lam, Ivan Pasic, Armin Gerbitz, Auro Viswabandya, Dennis Dong Hwan Kim, Jonas Mattsson, Fotios Michelis

Blood (2024) 144 (Supplement 1): 2151.

https://doi.org/10.1182/blood-2024-204249

Published: 2024

Journal Articles

Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in the Patients with CCAAT Enhancer-Binding Protein a Gene (CEBPA) Mutated Acute Myeloid Leukemia

Swe Mar Linn, Nihar Desai, Steven M. Chan, Andre C. Schuh, Aniket Banker, Marta Beata Davidson, Guillaume Richard-Carpentier, Aron Shimmer, Dawn C. Maze, Karen Yee, Mark D. Minden, Vikas Gupta, Tracy Stockley, Hassan Sibai, Jose-Mario Capo-Chichi, Anne Maria Tierens, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 1570.

https://doi.org/10.1182/blood-2024-211434

Published: 2024

Journal Articles

Retrospective Study to Compare Treatment Outcomes of Asciminib Vs. Ponatinib in 99 Patients with T315I Mutated Chronic Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 3149.

https://doi.org/10.1182/blood-2024-205681

Published: 2024

Journal Articles

Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Ahmed Alnughmush, Ruah Alyamany, Mats Remberger, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Dennis Dong Hwan Kim, Fotios Michelis, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 7285.

https://doi.org/10.1182/blood-2024-202708

Published: 2024

Journal Articles

Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?

Blood (2024) 144 (Supplement 1): 7418.

https://doi.org/10.1182/blood-2024-206153

Published: 2024

Journal Articles

Both Pre- and Post-Allogeneic Stem Cell Transplant Ferritin Are Associated with Relapse: A Large Single Centre Retrospective Study

Caden Chiarello, Mats Remberger, Carol Chen, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Wilson Lam, Arjun Law, Jonas Mattsson, Fotios Michelis, Ivan Pasic, Auro Viswabandya, Igor Novitzky-Basso

Blood (2024) 144 (Supplement 1): 7384.

https://doi.org/10.1182/blood-2024-203265

Published: 2024

Journal Articles

Impact of Cyclosporine Exposure Levels on Outcomes in Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis

Ahmed Alnughmush, Mats Remberger, Vathany Kulasingam, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Dennis Dong Hwan Kim, Armin Gerbitz, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Fotios Michelis

Blood (2024) 144 (Supplement 1): 7358.

https://doi.org/10.1182/blood-2024-202535

Published: 2024

Journal Articles

Survival and Engraftment Post Allogeneic Hematopoietic Stem Cell Transplantation: ABO Mismatch Matters in RIC

Nihar Desai, Tommy Alfaro Moya, Igor Novitzky-Basso, Ivan Pasic, Wilson Lam, Fotios Michelis, Armin Gerbitz, Dennis Dong Hwan Kim, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Arjun Law

Blood (2024) 144 (Supplement 1): 687.

https://doi.org/10.1182/blood-2024-194886

Published: 2024

Journal Articles

Clinical Relevance of NPM1 Quantitative PCR As Standard of Care with Different Cut-Off Values on Treatment Outcomes in NPM1-Mutated Acute Myeloid Leukemia Patients

Donna Zhe Sian Eng, Andre C. Schuh, Aniket Bankar, Marta Beata Davidson, Guillaume Richard-Carpentier, Hassan Sibai, Dawn C. Maze, Karen Yee, Aaron D Schimmer, Vikas Gupta, Tracy Stockley, Jose-Mario Capo-Chichi, Chen Steven, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 6172.

https://doi.org/10.1182/blood-2024-211783

Published: 2024

Journal Articles

Olverembatinib (HQP1351) Overcomes Resistance/Intolerance to Asciminib and Ponatinib in Patients (pts) with Heavily Pretreated Chronic-Phase Chronic Myeloid Leukemia (CP-CML): A 1.5-Year Follow-up Update with Comprehensive Exposure-Response (E-R) Analyses

Blood (2024) 144 (Supplement 1): 3151.

https://doi.org/10.1182/blood-2024-207139

Published: 2024

Journal Articles

Prognostic Implication of Framingham Risk Score As a Comorbidity Measure on Treatment Outcomes Following First-Line Tyrosine Kinase Inhibitor in Newly Diagnosed CML Patients

May Chiu, Maria Agustina Perusini, Jaeyoon John Kim, Danielle Pyne, Muzaffar Bhatti, Anthea Travas, Oyeronke Ayansola, Amirtha Ambalavanan, Jenny Ho, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 1768.

https://doi.org/10.1182/blood-2024-204999

Published: 2024

Journal Articles

Expanding the Donor Pool, the Number of Antigen Mismatches Has No Impact in the Outcomes of Haploidentical Stem Cell Transplantation with Peripheral Blood Stem Cells and Dual T Cell Depletion

Tommy Alfaro, Nihar Desai, Carol Chen, Maria Queralt Salas, Igor Novitzky-Basso, Wilson Lam, Ivan Pasic, Arjun Datt Law, Fotios Michelis, Jeffrey H. Lipton, Armin Gerbitz, Rajat Kumar, Dennis Dong Hwan Kim, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 2183.

https://doi.org/10.1182/blood-2024-199206

Published: 2024

Journal Articles

Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Blood (2024) 144 (Supplement 1): 7308.

https://doi.org/10.1182/blood-2024-202554

Published: 2024

Journal Articles

Real-World Efficacy of Belumosudil in Treating Fibrotic Symptom Burden in Chronic Gvhd: Modified Lee Symptom Score Assessment after Multiple Treatment Failures

Nihar Desai, Arjun Law, Christopher Lemieux, Keven Vachon, Kareem Jamani, Mohamed Elemary, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 7353.

https://doi.org/10.1182/blood-2024-211615

Published: 2024

Journal Articles

Retrospective Evaluation of BCR::ABL Kinase Domain Mutation Profiles and Treatment Outcomes in Patients with Chronic Myeloid Leukemia to Confirm Clinical Relevance of in Vitro Sensitivity-Based Treatment Switch: Real-World Experience

Maria Agustina Perusini, Eleanore Louise Musick, Filza Gul, May Chiu, Mohammad Alwadi, Noora Obaidallah, Jaeyoon John Kim, Danielle Pyne, Jose-Mario Capo-Chichi, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 3810.

https://doi.org/10.1182/blood-2024-210449

Published: 2024

Journal Articles

Asciminib (ASC) Demonstrates Favorable Safety and Tolerability Compared with Each Investigator-Selected Tyrosine Kinase Inhibitor (IS TKI) in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Pivotal Phase 3 ASC4FIRST Study

Jorge E. Cortes, Andreas Hochhaus, Timothy P Hughes, Jianxiang Wang, Dong-Wook Kim, Dennis Dong Hwan Kim, Jiri Mayer, Yeow Tee Goh, Philipp le Coutre, Gabriel Etienne, Naoto Takahashi, Inho Kim, David Andorsky, Ghayas C. Issa, Felice Bombaci, Shruti Kapoor, Rajendra Jinwal, Lillian Yau, Richard Larson

Blood (2024) 144 (Supplement 1): 475.

https://doi.org/10.1182/blood-2024-203757

Published: 2024

Journal Articles

Multicenter, Real-World Experience Study of FLT3-Inhibitor Post-Transplant Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia with FLT3-ITD

Yomna Eissa, Hyeoung-Joon Kim, Joon Ho Moon, Robert Zeiser, Francesca Biavasco, Christopher Lemieux, Mohamed Elemary, Varun Mehra, Mili Shah, Ahmed Alotaibi, Yu Cai, Xianmin Song, Jae-Sook Ahn, Sang Kyun Sohn, Mohsen Al Zahrani, Muhned Alhumaid, Hee-Je Kim, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 778.

https://doi.org/10.1182/blood-2024-208622

Published: 2024

NARROW

Leptin-Enhanced JAK-STAT Signaling in Acute Myeloid Leukemia-Derived Mesenchymal Stromal Cells and Its Implications for Disease Progression

The Use of Post-Transplant Cyclophosphamide Leads to Increased Cardiac Complications without Affecting Survival in Haploidentical Stem Cell Transplantation

Real-World Experience of Asciminib Treatment and Its Clinical Outcomes Including Cardiovascular (CV) Event-Free, Failure-Free Survival Associated with CV Comorbidity and Framingham CV Risk Score in Patients with Chronic Myeloid Leukemia

The Effect of Smoking and Pre-Transplant Pulmonary Comorbidity on the Incidence of Lung Graft Versus Host Disease and Post Transplant Outcomes

Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in the Patients with CCAAT Enhancer-Binding Protein a Gene (CEBPA) Mutated Acute Myeloid Leukemia

Retrospective Study to Compare Treatment Outcomes of Asciminib Vs. Ponatinib in 99 Patients with T315I Mutated Chronic Myeloid Leukemia

Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?

Both Pre- and Post-Allogeneic Stem Cell Transplant Ferritin Are Associated with Relapse: A Large Single Centre Retrospective Study

Impact of Cyclosporine Exposure Levels on Outcomes in Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis

Survival and Engraftment Post Allogeneic Hematopoietic Stem Cell Transplantation: ABO Mismatch Matters in RIC

Clinical Relevance of NPM1 Quantitative PCR As Standard of Care with Different Cut-Off Values on Treatment Outcomes in NPM1-Mutated Acute Myeloid Leukemia Patients

Olverembatinib (HQP1351) Overcomes Resistance/Intolerance to Asciminib and Ponatinib in Patients (pts) with Heavily Pretreated Chronic-Phase Chronic Myeloid Leukemia (CP-CML): A 1.5-Year Follow-up Update with Comprehensive Exposure-Response (E-R) Analyses

Prognostic Implication of Framingham Risk Score As a Comorbidity Measure on Treatment Outcomes Following First-Line Tyrosine Kinase Inhibitor in Newly Diagnosed CML Patients

Expanding the Donor Pool, the Number of Antigen Mismatches Has No Impact in the Outcomes of Haploidentical Stem Cell Transplantation with Peripheral Blood Stem Cells and Dual T Cell Depletion

Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Real-World Efficacy of Belumosudil in Treating Fibrotic Symptom Burden in Chronic Gvhd: Modified Lee Symptom Score Assessment after Multiple Treatment Failures

Retrospective Evaluation of BCR::ABL Kinase Domain Mutation Profiles and Treatment Outcomes in Patients with Chronic Myeloid Leukemia to Confirm Clinical Relevance of in Vitro Sensitivity-Based Treatment Switch: Real-World Experience

Asciminib (ASC) Demonstrates Favorable Safety and Tolerability Compared with Each Investigator-Selected Tyrosine Kinase Inhibitor (IS TKI) in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Pivotal Phase 3 ASC4FIRST Study

Multicenter, Real-World Experience Study of FLT3-Inhibitor Post-Transplant Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia with FLT3-ITD

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only